What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
His scientific interests lie mostly in Alzheimer's disease, Dementia, Internal medicine, Pathology and Biomarker.
His Alzheimer's disease study combines topics from a wide range of disciplines, such as Positron emission tomography and Psychiatry, Neuroimaging.
The study incorporates disciplines such as Temporal cortex, Cognition, Differential diagnosis, Magnetic resonance imaging and Neurology in addition to Dementia.
The Internal medicine study combines topics in areas such as Gastroenterology and Oncology.
Niklas Mattsson has researched Pathology in several fields, including Severity of illness and Cerebral blood flow.
His Biomarker research is multidisciplinary, incorporating perspectives in Csf biomarkers and Bioinformatics.
His most cited work include:
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (893 citations)
- The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers (301 citations)
- Amyloid biomarkers in Alzheimer's disease. (279 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cerebrospinal fluid, Internal medicine, Pathology, Disease and Alzheimer's disease.
He interconnects Immunology, Amyloid precursor protein, Magnetic resonance imaging, Cognitive decline and Vascular dementia in the investigation of issues within Cerebrospinal fluid.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology, Neurology and Oncology.
His Pathology study frequently draws parallels with other fields, such as Neuroimaging.
His biological study spans a wide range of topics, including Cognition, Neuroscience and Clinical trial, Bioinformatics.
His studies deal with areas such as Amyloid beta, Cohort study, Psychiatry, Apolipoprotein E and Precuneus as well as Alzheimer's disease.
He most often published in these fields:
- Cerebrospinal fluid (64.97%)
- Internal medicine (54.78%)
- Pathology (67.83%)
What were the highlights of his more recent work (between 2018-2020)?
- Internal medicine (54.78%)
- Disease (45.54%)
- Neurology (28.34%)
In recent papers he was focusing on the following fields of study:
Niklas Mattsson spends much of his time researching Internal medicine, Disease, Neurology, Oncology and Dementia.
His work on Cognitive decline as part of general Internal medicine research is often related to Enolase, thus linking different fields of science.
His studies in Disease integrate themes in fields like Synapse, Neuroimaging, Gene and Cancer research.
His Neurology research includes themes of Area under the curve, Neurodegeneration, Emergency medicine, Serum biomarkers and Alzheimer's disease.
His work deals with themes such as Biomarker, Positron emission tomography and Cognition, which intersect with Dementia.
His Cerebrospinal fluid study improves the overall literature in Pathology.
Between 2018 and 2020, his most popular works were:
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. (157 citations)
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis (154 citations)
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (135 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
His primary areas of study are Neurology, Dementia, Internal medicine, Biomarker and Alzheimer's disease.
The various areas that he examines in his Neurology study include Neuroimaging and Neurodegeneration.
Neurodegeneration is a subfield of Pathology that Niklas Mattsson investigates.
Niklas Mattsson has included themes like Positron emission tomography, Cognition and Atrophy in his Dementia study.
His Internal medicine research focuses on Oncology and how it connects with Amyloid beta and Posterior cingulate.
His Biomarker research integrates issues from Frontotemporal dementia, Disease and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
